Literature DB >> 2805341

Analysis and HPLC fractionation of urine from patients with cystic fibrosis, chronic lung diseases and normal controls.

T M Guman-Wignot1, J Kaufman, D S Holsclaw, I R Schmoyer, J A Alhadeff.   

Abstract

The amounts of creatinine, protein, carbohydrate and sialic acid in the urine of 19 patients with cystic fibrosis (CF), 12 normal controls and 11 pathological controls with chronic lung disease have been determined. The mean creatinine excretion levels of the total CF group as well as the CF subgroups are significantly decreased when compared to normal controls but comparable to pathological controls. Mean urinary protein levels appear to be increased in patients with CF compared to normal controls and pathological controls but the increased levels resulted from factors (e.g., presence of diabetes mellitus) other than CF. No significant differences were found in amounts of total carbohydrate and sialic acid in urine and fractionated urinary preparations for the total group of nondiabetic patients with CF when compared to both normal and pathological controls. HPLC fractionation of low Mr (less than 10,000 Daltons) urinary preparations indicated the presence of an unknown peak in all of the antibiotic-treated CF patients, 43% of CF patients on low or no medication, 17% of the normal controls and 9% of the pathological controls. The present results illustrate the importance of including appropriate pathological controls and dividing patients with CF into subgroups according to clinical factors and types of therapy employed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805341     DOI: 10.1016/s0009-9120(89)80036-0

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population.

Authors:  Brandie D Wagner; Frank J Accurso; Theresa A Laguna
Journal:  J Cyst Fibros       Date:  2010-03-15       Impact factor: 5.482

Review 2.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.